DHHS, NIH News  
 
 
National Cancer Institute (NCI)

EMBARGOED FOR RELEASE
Wednesday, September 27, 2006
1:00 p.m. ET


Subscribe
  CONTACT:
NCI Media Relations Branch
301-496-6641

News Advisory
NCI Creates Network of Clinical Proteomic Technology Centers for Cancer Research
What:

Clinical Proteomic Technology Assessment for Cancer teams
The National Cancer Institute (NCI), part of the National Institutes of Health, will host a telebriefing to announce five Clinical Proteomic Technology Assessment for Cancer (CPTAC) teams. A major component of its $104 million, five-year Clinical Proteomics Technologies Initiative, the CPTAC awards total $35.5 million over five years.

The CPTAC teams will bring complementary expertise to assess the full spectrum of measurement technologies for proteins and peptides relevant to clinical cancer research and practice. The network’s collaborative efforts will guide and provide resources to the broader cancer research community, enabling researchers conducting cancer-related protein research at different laboratories to use proteomic technologies and methodologies to directly compare their work. Standardized technologies and methodologies are critically needed in current cancer proteomic research.

Who: Anna D. Barker, Ph.D., NCI deputy director, advanced technologies and strategic partnerships
Lee Hartwell, Ph.D.,
president and director, Fred Hutchinson Cancer Research Center
Steven A. Carr, Ph.D.,
Broad Institute of MIT and Harvard
Joe Gray, Ph.D.,
University of California, San Francisco/Lawrence Berkeley National Laboratory
Daniel C. Liebler, Ph.D.,
Vanderbilt University School of Medicine
Fred E. Regnier, Ph.D.,
Purdue University
Paul Tempst, Ph.D.
, Memorial Sloan-Kettering Cancer Center
When: Wednesday, September 27, 2006 1:00 p.m. - 2:00 p.m. EDT
The media briefing is available to reporters via a toll-free conference line at
1-866-755-5928 (Teleconference number: 7211683) in the United States only.
Note: The briefing will begin promptly at 11:00 a.m. EDT. Reporters should dial in 5-10 minutes before the start of the conference. Following the presentations, an operator will inform you that the session is open to questions. To ask a question, press *1 on your touchtone phone. You will hear a tone to indicate your question is pending. A transcript of the briefing will be available as soon as possible following the briefing at http://proteomics.cancer.gov.

The National Institutes of Health (NIH) — The Nation's Medical Research Agency — includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.


NIH logo   Home > News & Events
Subscribe to receive future NIH news releases.